Securities. Understanding Structures and Risks of Exchange Traded Funds

Similar documents
Designated Market Maker

Designated Market Maker. Reference Index

Lyxor Asia 10US$(P60) SGX-ST Listing Date 19 October 2006

Principal Listing Exchange for each Fund: Cboe BZX Exchange, Inc.

SGX-ST Listing Rules. Practice Note 3.1. Term Sheet For Debentures and Funds

EXCHANGE TRADED CONCEPTS TRUST. REX VolMAXX TM Long VIX Futures Strategy ETF. Summary Prospectus March 30, 2018, as revised April 25, 2018

Global Investment Opportunities and Product Disclosure

AMF position ETFs and other UCITS issues

MULTI UNITS FRANCE - LYXOR UCITS ETF MSCI AC ASIA EX JAPAN INFORMATION TECHNOLOGY TR (the Fund )

Singapore Fixed Income Indices (SFI) Weekly

ETFs: A BEGINNER S GUIDE. November 2018

Explanation of Risks Associated With Exchange-Traded Derivative Products. 1. Risks Associated with Structured Products 2

Explanation of Risks Associated With Exchange-Traded Derivative Products. 1. Risks Associated with Structured Products...2

PRODUCT HIGHLIGHTS SHEET

An Introduction to Exchange Traded Products

ETP Due Diligence Guide

Bringing Exchange Traded Commodities to the World s Stock Exchanges

The shares of the Sub-Funds may trade at a discount or premium to their net asset value ( NAV ).

INVESTMENT SERVICES RULES FOR RETAIL COLLECTIVE INVESTMENT SCHEMES

Risk Explanation for Exchange-Traded Derivatives

The Manager does not intend to pay or make any distributions or dividends Financial year end:

Wing Lung Bank Limited

Vanguard ETFs. A comprehensive guide for financial advisers

ETFs for private investors

ETP Due Diligence Guide

Hang Seng H-Share Index ETF (stock code : 2828) Hong Kong Offering Document. 19 November Hang Seng Investment Management Limited

50 million European Style Cash Settled Index Put warrants expiring on 29 November 2018 relating to the Hang Seng Index (the "Warrants")

50 million European Style Cash Settled Index Call warrants expiring on 29 November 2018 relating to the Hang Seng Index (the "Warrants")

PRODUCT HIGHLIGHTS SHEET

Date. Listing. Warrant Agent

DBX ETF Trust. Statement of Additional Information. Dated October 2, 2017, as supplemented June 6, 2018

P R O D U C T H I G H L I G H T S S H E E T

The risk types set out below could have an impact on each type of financial instrument:

RISK DISCLOSURE STATEMENT

Investment Risk Disclosures

RISK DISCLOSURE STATEMENT FOR PROFESSIONAL CLIENTS AND ELIGIBLE COUNTERPARTIES AUSTRALIA AND NEW ZEALAND BANKING GROUP LIMITED LONDON BRANCH

Deutsche Börse Group

FundLogic Alternatives plc. Promoter and Distributor Morgan Stanley & Co. International plc. Supplement dated 6 July 2018

PRODUCT KEY FACTS. Quick facts. BOCHK Wealth Creation Series BOCHK All Weather Asian Bond Fund. April Issuer: BOCHK Asset Management Limited

PRODUCT HIGHLIGHTS SHEET CIMB-PRINCIPAL PREFERRED SECURITIES FUND

Singapore Fixed Income Indices (SFI) Weekly

Offering Series A and Series O units of the following Phillips, Hager & North investment funds:

Hull Tactical US ETF EXCHANGE TRADED CONCEPTS TRUST. Prospectus. March 30, 2018

SIMPLIFIED PROSPECTUS

HSBC Institutional Trust Services (Asia) Limited Ongoing charges over a year*: 0.98% Estimated annual tracking Estimated to be -1.

Equity Linked Deposits (Put Option)

Risk Disclosure Statement (Investment Account)

Equity-Linked Deposit. DBS Bank (Hong Kong) Limited

Quick facts St. James s Place Unit Trust Group Limited

Hull Tactical US ETF EXCHANGE TRADED CONCEPTS TRUST. Prospectus. April 1, 2019

ESMA guidelines on ETFs and other UCITS issues

MD Family of Funds 2018 INTERIM FINANCIAL STATEMENTS

Confirmation Letter. Name of Client/Company: Account No.: Re: Knowledge of Trading Derivative Products

Securities Lending Policy

ETFs for private investors

PRODUCT HIGHLIGHTS SHEET

No securities regulatory authority has expressed an opinion about these shares and it is an offence to claim otherwise.

Risk Disclosure Statement Securities Trading Account

NewFunds NewSA Index Exchange Traded Fund. Corporate and Investment Banking

PRODUCT HIGHLIGHTS SHEET

An introduction to Exchange Traded Products

PRODUCT HIGHLIGHTS SHEET

ETFs explained ADVISORY. Member of the London Stock Exchange

FundLogic Alternatives plc. Promoter and Distributor Morgan Stanley & Co International plc. Supplement dated 31 July 2015

Product Key Facts Franklin Templeton Asia Fund Series Franklin Select Global Multi-Asset Income Fund Last updated: April 2018

LAZARD US FUNDAMENTAL ALTERNATIVE FUND

STATE STREET GLOBAL ADVISORS GROSS ROLL UP UNIT TRUST

SG Issuer. Launch Date 3 July Expiry Date

db X-trackers ETFs A 10 Step Guide to Exchange Traded Funds

China Post Global Funds

GLOBEVEST CAPITAL SECURED PUT WRITING FUND Series A, AH, A3, A5, F, FH, F6H, I, IH, O and OH Units

Quick facts St. James s Place Unit Trust Group Limited

Direxion Daily Energy Bear 3X Shares: ERY Hosted on NYSE Arca

9 Questions Every ETF Investor Should Ask Before Investing

Risks. Complex Products. General risks of trading. Non-Complex Products

BlackRock Asset Management North Asia Limited Investment Advisers:

Designated Market Maker. Index ) N/A Traded Currency Singapore dollars (S$)

ETF shares, Series A shares, Series F shares, Series XA shares and Series XF shares

Xtrackers USD Emerging Markets Bond Quality Weighted UCITS ETF. Supplement to the Prospectus

Description of financial instruments nature and risks

GLOBAL OPPORTUNITIES FUND (THE FUND )

Questions and Answers. ESMA s guidelines on ETFs and other UCITS issues

PRODUCT KEY FACTS HENDERSON HORIZON FUND PAN EUROPEAN PROPERTY EQUITIES FUND

PRODUCT HIGHLIGHTS SHEET

Fidelity FIRST Global Fund

MACKENZIE MUTUAL FUNDS

HSBC S&P 500 UCITS ETF

Description. As above, except the periodic coupons and face value are indexed to inflation.

HSBC ETFs PLC Prospectus. 17 February 2017

PRODUCT HIGHLIGHTS SHEET

RE: Modification of Sub-fund No. 31 of the MULTI UNITS FRANCE SICAV fund (the Fund ), indicated below:

PRODUCT KEY FACTS Value Partners Greater China High Yield Income Fund

HKD counter: 1,000 units RMB counter: 1,000 units Fund Manager:

Bond Buyer Conference Municipal Credit Default Swaps

St. James s Place Unit Trust Group Limited. Invesco Asset Management Limited (external delegation, in the United Kingdom)

BlackRock Global Funds US Dollar Bond Fund

An introduction to Exchange Traded Products

PRODUCT KEY FACTS. Quick facts Manager: Trustee: Custodian: Dealing frequency: Base currency: Ongoing charges over a year:

MAX MULTI-ASSET ADVANTAGE FUND (FUND SUMMARY) Schroder Investment Management (Singapore) Ltd

The CBOE Vest Family of Funds

Transcription:

Securities Understanding Structures and Risks of Exchange Traded Funds

1

Table of Contents Introduction 3 What is an Exchange Traded Fund ( )? 3 Replication Methodologies 4 Direct Replication 5 Full Replication 5 Representative Sampling 5 Synthetic Replication 6 Derivative Embedded 6 Swap Based 7 Risks of an? 10 Fundamental Risks 10 Additional Risks 11 My Checklist 12 2

Introduction In this document, we focus on the recent developments in the Singapore s market, with specific attention paid to potential risks arising from synthetic s¹ and securities lending transactions. What is an Exchange Traded Fund ( )? An is an open-ended investment fund² that aims to replicate the performance of a published market index. It is listed and traded on a stock exchange, and investors may buy or sell units to participate in the performance of the underlying index which tracks equities, fixed income, commodities or money market instruments. Investors typically use to gain exposure to all the constituents of the index, thereby diversifying their portfolio without having to purchase individual assets underlying the index. Cash Buyers of Units Sellers of Units SGX Cash Cash Authorised Participants Investors may refer to the SGX website at www.sgx.com for the full list of SGX Listed s. Generally, investors rely on the net asset value ( NAV ) of an to estimate the fair value of an, which is calculated once at the end of each trading day. The NAV is published on the issuer s website or SGXNET daily with a time delay. It is important to note that the NAV of an differs from the price at which it is traded. As an trades like a stock, it is quoted at bid and ask prices on the stock exchange. It could be traded at a price higher than its NAV (at a premium) or below the NAV (at a discount). ¹ Refer to the section titled Replication Methodologies for a further discussion on synthetic s. ² Open-endedness of an implies that the units in the market are not fixed and subject to market demand where new units can be created/ redeemed from time to time. This is unlike shares which generally have fixed amount of units in the market. 3

Replication Methodologies There are two common types of index replication method, namely direct replication and synthetic replication. The more commonly known replication method, the direct replication method, replicates the performance of an index by investing in the index s constituents. It is also known as cash based or physically replicated. Direct replication comes in two different forms, namely: (a) the full replication, where an would hold all assets underlying an index in the exact proportion with the index; and (b) the representative sampling method, where an will invest in a subset of index constituents, usually the more dominant underlying, to reduce number of securities held while tracking the index as closely as possible. The representative sampling method is generally used when some of the components of the index tracked are not liquid or easily available. An that uses synthetic replication utilises derivative instruments and/or OTC transactions to replicate the index s performance without directly holding the underlying assets. They further branch into two forms: (a) the derivative embedded that purchases derivative instruments from other counterparty(ies) in exchange for the index performance; and (b) the swap-based that pays a fee or the collateral performance to a third counterparty(ies) in exchange for the index s performance. For the ease of identification, SGX has required the counter names for all synthetic s to be marked with the symbol X. Direct Replication Index Replication Method Synthetic Replication Full Replication Representative Sampling/ Derivative Embedded Swap - Based Unfunded Structure Funded Structure 4

Direct Replication Full Replication Investors units after expenses selective constituents will directly hold all constituents within the index to replicate the performance of an index. The returns of the s portfolio, after expenses, will be passed on to investors in accordance with the number of units held. Representative Sampling Investors units Performance of portfolio after expenses selective constituents Performance of portfolio (based on selective constituents held) will hold a subset of the constituents of the index to replicate the performance of an index as closely as possible. The returns of the s portfolio, after expenses, will be passed on to investors in accordance to the number of units held. Note Please refer to Securities Lending Risks in the Risks Section for further details. 5

Synthetic Replication Derivative Embedded units derivatives Investors Derivative Instruments after expenses Held for Performance of index derivatives Collateral Pool Deposits collateral Derivatives Issuer(s) ) Held by Custodian A derivative embedded purchases derivative instruments from a third party and these instruments are contractual obligations that binds the issuer(s) to deliver the index performance to the fund. Investors are therefore relying on the creditworthiness of the derivative issuer(s) to deliver the performance of the index to the fund. A derivative embedded must comply with the net counterparty exposure requirement under the Collective Investment Scheme ( CIS ) or the Undertakings for Collective Investment in Transferrable Securities ( UCITS ), where only a maximum of 10% net counterparty exposure is allowed. With this maximum net counterparty exposure, investors will risk losing only up to 10% of the value of the fund in the event of a counterparty default. Typically, the derivative issuer will deposit collateral for the balance 90% with a third counterparty custodian, and the collateral will be owned by the trustee of the. Note Refer to Securities Lending Risks in the Risks Section for further details. Refer to Swap Counterparty Risks in the Risks Section for further details. 6

Swap Based Swap Based s listed on SGX must also comply with the 10% net counterparty exposure requirement under either the CIS or the UCITS. In order to comply with the requirement, the swap counterparty must collateralise the, which could be done through two methods - the fully funded structure or the unfunded structure. Unfunded Swap Based Swap Agreement Investors units Collateral returns Swap Counterparty after expenses Collateral returns collateral Performance of index Invest in index constituents Collateral Pool Index constituents Held by Custodian The unfunded swap based enters into a swap agreement with swap counterparty to obtain the performance of the index. Under the swap agreement, the will be using the proceeds from the sale of units, to purchase and hold a pool of collateral placed with a third party custodian. The returns generated by the collateral held by the, will then be exchanged with the swap counterparty in return for the performance of the index. Due to the limit imposed on net counterparty exposure, the daily value of the collateral pool must be rebalanced on a daily basis to ensure that its value is at least 90% of the NAV of the. In the event of a default, the may choose to liquidate this pool of collateral to repay its investors. Note Refer to Securities Lending Risks in the Risks Section for further details. Refer to Swap Counterparty Risks in the Risks Section for further details. 7

Fully Funded Swap Based Custodian Held by Collateral pledged to Collateral Pool Swap Agreement Deposits Investors units Collateral returns Swap Counterparty after expenses Performance of index Invest in index constituents Index constituents Similar to the unfunded structure, the fully funded swap will be required to deliver performance of the collateral it holds to the swap counterparty in exchange for the performance of the index. However, in this structure, the will be transferring its sale proceeds to the swap counterparty that will purchase a pool of collateral to be placed with a third party custodian. This pool of collateral will also be pledged in favour of the, to be liquidated in the event of a default. Note Refer to Securities Lending Risks in the Risks Section for further details. Refer to Swap Counterparty Risks in the Risks Section for further details. 8

Funded and Unfunded Swap Based Custodian n Held by Collateral pledged to Collateral Pool Swap Agreement Deposits Investors units after expenses Collateral Returns Performance of index Swap Counterparty Collateral returns collateral Performance of index Index constituents Invest in index constituents Collateral Pool Held by Custodian The structure is a combination of both funded and unfunded swap arrangements. The enters into a swap agreement with a third party to obtain the performance of the index. The swap will then be collateralised through the adoption of both kinds of swap arrangements, (a) the unfunded swap, where the manager would use proceeds from the sale of units to purchase collateral which will be pledged to the ; and (b) the funded swap, where the swap counterparty would deposit collateral with a third party custodian, and pledge the collateral in favour of the. Both methodologies aim to limit the s overall exposure to the swap counterparty to 10% of the s NAV. Note Refer to Securities Lending Risks in the Risks Section for further details. Refer to Swap Counterparty Risks in the Risks Section for further details. 9

Risks of an? Fundamental Risks Bid-Ask Spreads In the creation and redemption process, an will be required to acquire or dispose of underlying index securities in order to mimic the performance of the index. If the underlying index securities are illiquid and thinly traded, the availability of underlying will decrease, causing the bid-ask spread 3 of the underlying to widen. The failure of the creation and redemption will cause units to be traded at a premium or discount, and consequently, the tracking error will increase. Tracking Error Tracking error is a measure of how the value of the may deviate from the value of the underlying which it tracks. Tracking error arises from various circumstances, such as: Market Risks As with other securities, the underlying which tracks is susceptible to market volatility. Change of market condition will affect the price of the underlying, which constitutes the NAV of the, leading to a change in price of the. I. Transaction costs the cost of buying and selling of securities, or fees of swap transactions within the portfolio will be charged to the, thereby causing a reduction in performance from its underlying. II. Portfolio holdings if the assets held in the portfolio are different from the underlying assets tracked, the replicated performance may not be the same as the underlying. III. Replication methodology synthetic replication will improve an s ability to track, as it is the swap counterparty s obligation to deliver the performance of the underlying, subject to a small fee for the swap arrangement. However, this will expose the to the swap counterparty s default risk. IV. Types of investments an that buys into futures contracts will be required to roll them repeatedly (where the must sell an expiring contract to buy the next contract at a different price). If price of the next contract is higher, also known as a contango effect, a loss is recorded. If the price of the next contract is lower, a backwardation effect, again is recorded. The gains and losses will affect the performance of the, causing tracking error. V. Cash holdings such as dividends from the securities held by an, may be held as cash in the until the payout date, and investors will lose out on the possible gain from reinvesting or the interest payment of the holdings. VI. Additional features an that conducts currency hedging may incur hedging costs in a volatile market, leading to a reduction in the s performance. Foreign Exchange Risks Foreign exchange risks could arise when (i) the currency of the actual assets held by the differs from the denomination currency of the or (ii) when the trading currency of the differs from the denomination currency of the. Fluctuation of the foreign exchange may affect the price and the realised gain of an. Liquidity Risks Active trading of the will not be maintained when the authorised participants or market maker cease to perform its obligations to provide continuous quote in the. The result of this is that the buyer may not be able to buy or sell an on a timely manner at a fair price. Most of the s are collateralised or backed by a pool of assets, providing investors some safeguards to their investments in the event of a default. It is important to note that some of these assets or collateral may not be liquid, and it may be difficult to dispose them quickly, leading to a potential erosion of the value that investors were initially entitled to. Various rules have been put in place to ensure that collateral posted comply with liquidity requirements laid out by the regulatory authorities, but there is no guarantee to the realisable value of the collateral. Participatory-notes, for example, may not have a secondary market for trading purpose. 3 Bid-ask spread is determined by the difference of the price that a buyer is willing to pay for an asset and the price that a seller is willing to sell. 10

Additional Risks Securities Lending Risks Some s in the market engage in asset or collateral lending. Cash-based s and synthetic s may carry out securities lending transactions to obtain additional returns. A portion of the income from the securities lending transactions could be used to offset costs incurred by the s and to improve returns to the investors. Collateral assets received by the for the securities lending transactions, which were intended to act as safeguards for investors may not be fully recoverable in a timely manner when needed and/or in the event the borrower defaults. The CIS and UCITS require securities lent to be fully collateralised with liquid securities. If securities lending is conducted it will be expressly stated in the offering document. Investors should look out for information on restrictions in securities lending, and collateral requirements to better understand the safeguards in place to protect their investments. Counterparty Risks Swap based synthetic s are also exposed to the default risks of its swap counterparty. In the event of a default, the fund, or the trustee is required to act in the best interest of investors to retrieve the assets or collateral pledged to the fund. Theoretically, investors should obtain at least 90% of the value of the, as prescribed by the net swap-counterparty exposure limit under the CIS requirement. However, the timeline required for the liquidation of the assets or collateral may not be spontaneous, and the delay will cause the valuation of the assets or collateral to vary. Derivatives-embedded synthetic s such as Participatory- Notes s are exposed to credit risk of the derivative issuer who is contractually bound to deliver the performance of the index. The default or insolvency of such P-notes issuer will substantially affect the s ability to meet any payment obligations to any return to its investors. Derivative embedded s are also subject to the net counterparty exposure limit of maximum 10%. These s would have to be collateralised, such that in the event of a default, investors may recover the collateral and/or the derivative instruments. It is also important for investors to note that the derivative instruments held by an may not be liquid, which would further deter investors from realising the residual value. In the event of a counterparty default, the liquidation process of the collateral held for the is not likely to be spontaneous and is subject to various jurisdictions governing the defaulting party. During the liquidation process, the value of the assets or collateral will continue to fluctuate with market s price movements. Therefore, realisable collateral value will also correspond to the upward price movement or downward price movement of the asset pool. Investors should refer to the Risks section of the prospectus prior to investing in any, as risks structures vary across all s.

My Checklist Questions Infomation that you should know Information on the What type of are you buying? Direct Replication nfull Replication nrepresentative Sampling What are the fundamental risks of the? What you should know about the additional features of the. Synthetic Replication nfunded Swaps nunfunded Swaps ncombination of Funded and Unfunded Swaps nderivatives-embedded nbid ask spread ntracking error nmarket risk nforeign exchange risk n liquidity risk (Refer to the offer documents for the description of these risks) Swap Counterparty(ies) nwhat are their credit ratings and default risk? nare there any conflicts of interest between the manager, the custodian and the counterparty? ndo they employ a funded or unfunded swap? nwhat is the level of collateralisation and how often are they measured? nwhat types of collateral will be pledged to you and how are they safeguarded? Securities Lending nis the borrower rated? ndid the issuer receive collateral for lending out the securities? nwhat kinds of collateral are allowed? nare the collateral liquid? nhow are the collateral reinvested? nwhat are the issuer s guidelines when selecting borrower/ reinvestment of collateral? nwhat is the level of collateral? Is the under collateralised? nhow often does the issuer monitor and rebalance the value of collateral to match the value? nhas the issuer disclosed the risks relating to securities lending?

Questions Infomation that you should know Information on the What you should know Hedging activity about the additional nis the involved in any form of hedging? features of the. nwhat are the implications of such activity? nare there any additional costs involved that would affect the performance of the? Foreign Currencies Exposure nwhich aspects of the would expose me to foreign currencies fluctuations? nwhat are the implications? What is my protection Other features nwhat are the additional risks and implications of these features? nare there additional costs incurred and will they affect my returns? nare there additional safeguards to these new features? nwhat am I entitled to in an event of default? nis there easy access to the assets/collateral held/pledged to the? nwhat types of collateral are pledged? Are they liquid? nin the event of a default, what are the procedures to liquidate my investment? nwhat recourse can I seek through my trustee? napproximately how much of my investment value will I be able to recover in the event of a default? nwhere can I look for more information on the above questions? Investors should refer to the introductory document, product highlight sheet and prospectus for more information to answer the above questions. Alternatively, investors can contact the managers of the s for more information. 13

Notes 14

This document is not intended for distribution to, or for use by or to be acted on by any person or entity located in any jurisdiction where such distribution, use or action would be contrary to applicable laws or regulations or would subject SGX to any registration or licensing requirement. This document is not an offer or solicitation to buy or sell, nor financial advice or recommendation for any investment product. This document has been published for general circulation only. It does not address the specific investment objectives, financial situation or particular needs of any person. Advice should be sought from a financial adviser regarding the suitability of any investment product before investing or adopting any investment strategies. Further information on this investment product may be obtained from www.sgx.com. Investment products are subject to significant investment risks, including the possible loss of the principal amount invested. Past performance of investment products is not indicative of their future performance. While SGX and its affiliates have taken reasonable care to ensure the accuracy and completeness of the information provided, they will not be liable for any loss or damage of any kind (whether direct, indirect or consequential losses or other economic loss of any kind) suffered due to any omission, error, inaccuracy, incompleteness, or otherwise, any reliance on such information. SGX is an exempt financial adviser under the Financial Advisers Act (Cap. 110) of Singapore. The information in this document is subject to change without notice. Singapore Exchange London Tokyo Beijing 2 Shenton Way, #19-00 SGX Centre 1, Singapore 068804 Main: (65) 6236 8888 Fax: (65) 6535 6994 www.sgx.com